Park Square has placed Mark Namchuk, Ph.D. as executive director of therapeutics translation at Harvard Medical School.
Harvard Medical School has named Mark Namchuk, PhD, a former pharmaceutical R&D executive with a background in immunology and bioorganic chemistry, as executive director of therapeutics translation. Namchuk, who joins Harvard Medical School from Alkermes, will assume his role on Jan. 2.
